The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK.

Authors:
Zhang T; Xu L; Guo X; Tao H; Liu Y and 3 more

Journal:
J Pharm Anal

Publication Year: 2023

DOI:
10.1016/j.jpha.2023.09.001

PMCID:
PMC10921247

PMID:
38464786

Journal Information

Journal Title: J Pharm Anal

Detailed journal information not available.

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"This work was supported by the 10.13039/501100001809Natural Science Foundation of China (Grant No.: 82130113), the “Xinglin Scholars” Research Promotion Program of 10.13039/501100008402Chengdu University of Traditional Chinese Medicine (Program No.: ZDZX2022005), the 10.13039/501100002858China Postdoctoral Science Foundation (Grant No.: 2021MD703800), and the Science Foundation for Youths of Science & Technology Department of Sichuan Province (Grant No.: 2022NSFSC1449). Figs. 2 and 3 and graphical abstract were partly generated using Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license”. The herbal durgs shown in Figs. 2 and 3 and graphical abstract available from: https://www.gbif.org. TaoZhang: Investigation, Data curation, Writing - Original draft preparation, Reviewing and Editing; Lei Xu: Writing - Original draft preparation; Xiaowei Guo: Investigation, Data curation; Honglin Tao: Investigation, Data curation; Yue Liu: Supervision; Xianfeng Liu: Writing -Reviewing and Editing; Yi Zhang: Resources, Writing - Reviewing and Editing, Supervision, Funding acquisition; Xianli Meng: Resources, Writing - Reviewing and Editing, Supervision, Funding acquisition."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025